U.S. Markets closed
  • S&P Futures

    3,763.00
    -26.50 (-0.70%)
     
  • Dow Futures

    30,568.00
    -213.00 (-0.69%)
     
  • Nasdaq Futures

    11,444.75
    -84.75 (-0.74%)
     
  • Russell 2000 Futures

    1,691.10
    -16.90 (-0.99%)
     
  • Crude Oil

    105.76
    0.00 (0.00%)
     
  • Gold

    1,804.70
    -2.60 (-0.14%)
     
  • Silver

    20.10
    -0.25 (-1.21%)
     
  • EUR/USD

    1.0469
    -0.0014 (-0.1361%)
     
  • 10-Yr Bond

    2.9720
    -0.1210 (-3.91%)
     
  • Vix

    28.71
    +0.55 (+1.95%)
     
  • GBP/USD

    1.2144
    -0.0031 (-0.2574%)
     
  • USD/JPY

    135.2380
    -0.4900 (-0.3610%)
     
  • BTC-USD

    20,271.81
    +196.54 (+0.98%)
     
  • CMC Crypto 200

    434.21
    +2.74 (+0.64%)
     
  • FTSE 100

    7,169.28
    -143.04 (-1.96%)
     
  • Nikkei 225

    26,159.53
    -233.51 (-0.88%)
     

Horizon Therapeutics plc to Present at the Goldman Sachs 43rd Annual Global Health Care Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

DUBLIN, June 06, 2022--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conference in June:

Goldman Sachs 43rd Annual Global Health Care Conference

  • Date: Tuesday, June 14, 2022

  • Presentation Time: 11 a.m. ET

The conference presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizontherapeutics.com. A replay of the webcast will be available for one year following the event.

About Horizon

Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220606005940/en/

Contacts

Investor Relations:
Tina Ventura
Senior Vice President,
Chief Investor Relations Officer
investor-relations@horizontherapeutics.com

U.S. Media:
Geoff Curtis
Executive Vice President, Corporate Affairs &
Chief Communications Officer
media@horizontherapeutics.com

Ireland Media:
Gordon MRM
Ray Gordon
ray@gordonmrm.ie